Metraipolis › archive › dc_acc73abdf89f
Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning — arXiv:2609.12264
- Source
- arXiv (en)
- Original
- https://arxiv.org/abs/2609.12264
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-16T03:15:37.755Z
- SHA-256 of the archived text
3d26b3d988a9eaa4cf43ec87fbe407051adb7b8cc90604a2fe197019ed2a6c42- Stable URL of this page
https://metraipolis.com/documento/dc_acc73abdf89f
How to cite
Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning — arXiv:2609.12264 — arXiv (en), https://arxiv.org/abs/2609.12264 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_acc73abdf89f (Metraipolis archive dc_acc73abdf89f, sha256 3d26b3d988a9eaa4cf43ec87fbe407051adb7b8cc90604a2fe197019ed2a6c42)
BibTeX
@misc{dcacc73abdf89f,
title = {Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning — arXiv:2609.12264},
howpublished = {arXiv (en)},
url = {https://arxiv.org/abs/2609.12264},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_acc73abdf89f; sha256 3d26b3d988a9eaa4cf43ec87fbe407051adb7b8cc90604a2fe197019ed2a6c42},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2609.12264. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Designing effective chemotherapy regimens is hindered by tumor heterogeneity and drug resistance, which complicate the deployment of patient-specific model-based optimal control across diverse populations. We develop and compare closed-loop deep reinforcement learning (DRL) dosing policies with continuous (TD3) and discrete (DQN) action spaces trained on a high-dimensional heterogeneous tumor model. The DRL policies are benchmarked against a Pontryagin's Maximum Principle (PMP)-derived open-loop benchmark. We assess generalization under parametric heterogeneity using a 100-patient virtual cohort with plus or minus 10 percent uniform perturbations in growth and drug-sensitivity parameters. Across this cohort, TD3 achieves higher average tumor reduction, while DQN yields tighter inter-patient dosing consistency, revealing a clear efficacy-consistency trade-off in this study. Our simulations assume full observation of all tumor subpopulations; translation to sparse and noisy clinical measurements will require partial-observability formulations and/or state estimation. Overall, the results show that simulation-trained DRL can learn state-dependent feedback dosing policies that complement open-loop optimal control benchmarks. Tema degli esploratori: agenti e intelligenza artificiale (retro-catalogo arXiv: annunci del 2026-09-14 in cs.LG). Categorie arXiv: Machine Learning (cs.LG) ; Systems and Control (eess.SY). Pagina del lavoro: https://arxiv.org/abs/2609.12264 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina. Letto il 2026-10-16T03:05:44.030Z dalla pagina https://arxiv.org/catchup/cs.LG/2026-09-14?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).